Ofer Levy
Harvard University
H-index: 67
North America-United States
Top articles of Ofer Levy
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells (vol 8, 189, 2023) | npj Vaccines | Julie Zimmermann Simon D van Haren Joann Diray-Arce Ignatius Ryan Adriawan Katharina Wørzner | 2023/12/22 |
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology | medRxiv | Hoang Van Phan Alexandra Tstisiklis Cole P Maguire Elias K Haddad Patrice M Becker | 2024 |
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality | The Journal of Clinical Investigation | Jeremy P Gygi Cole Maguire Ravi K Patel Pramod Shinde Anna Konstorum | 2024/5/1 |
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition | Nature communications | Benjamin S Haslund-Gourley Kyra Woloszczuk Jintong Hou Jennifer Connors Gina Cusimano | 2024/1/9 |
Sars-cov-2 antigen nanoparticles and uses there of | 2024/4/11 | ||
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study | Nature Communications | Al Ozonoff Naresh Doni Jayavelu Shanshan Liu Esther Melamed Carly E Milliren | 2024/1/3 |
Respiratory Infection-and Asthma-prone, Low Vaccine Responder Children Demonstrate Distinct Mononuclear Cell DNA Methylation Pathways | David Martino Nikki Schultz Ravinder Kaur Simon D Haren Nina Kresoje | 2024/4/3 | |
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells | npj Vaccines | Julie Zimmermann Simon D van Haren Joann Diray-Arce Ignatius Ryan Adriawan Katharina Wørzner | 2024 |
Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders | Journal of Molecular Biology | Sanya Thomas Jensen Pak Simon Doss-Gollin Kevin Ryff Elisabeth Beijnen | 2024/2/15 |
Pvrig polypeptides and methods of treatment | 2024/1/25 | ||
Precision vaccinology for infectious diseases | Mahbuba Rahman Mehdi Adeli Herb E Schellhorn Puthen Veettil Jithesh Ofer Levy | 2024/4/18 | |
Stimulator of Interferon Genes (STING) ligands and uses thereof | 2023/4/25 | ||
Integrative systems biology characterizes immune-mediated neurodevelopmental changes in murine Zika virus microcephaly | Iscience | Kimino Fujimura Amanda J Guise Tojo Nakayama Christoph N Schlaffner Anais Meziani | 2023/7/21 |
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients | Cell Reports Medicine | Joann Diray-Arce Slim Fourati Naresh Doni Jayavelu Ravi Patel Cole Maguire | 2023/6/20 |
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance | Journal of Allergy and Clinical Immunology | Timothy R O'Meara Etsuro Nanishi Marisa E McGrath Soumik Barman Danica Dong | 2023/11/1 |
Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant Recipients | Research Square | Charles Langelier Harry Pickering Joanna Schaenman Hoang Phan Cole Maguire | 2023/12/20 |
A simple, time-and cost-effective, high-throughput depletion strategy for deep plasma proteomics | Science Advances | Arthur Viode Patrick van Zalm Kinga K Smolen Benoit Fatou David Stevenson | 2023/3/29 |
Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations | Branden Lee Etsuro Nanishi Ofer Levy David J Dowling | 2023/6/19 | |
Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review | Frontiers in Pediatrics | Sanya Thomas Geoffrey Guenther Jared H Rowe Craig D Platt Akiko Shimamura | 2023/7/17 |
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen | npj Vaccines | Simon Doss-Gollin Sanya Thomas Byron Brook Kimia Abedi Célia Lebas | 2023/10/26 |